Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...
Cyclacel Pharmaceuticals, Inc. announced a 1-for-15 reverse stock split of its common stock, effective July 7, 2025, with trading commencing on a split-adjusted basis that day under the ticker symbol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results